Please assess the completion status of the following clinical trial:

Trial Title: T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Adult patients ( \> 18 years) requiring surgical intervention within 24 hours of diagnosis, for localized IAI infections (i.e extending beyond the organ wall but confined near the hollow viscus, mild to moderate in severity):~* Acute appendicitis: Ruptured or perforated with abscess~* Acute diverticulitis with perforation and/or abscess~* Acute cholecystitis (including gangrenous) with either rupture or perforation~* Acute gastric and duodenal ( \> 24 hours) perforation~* Traumatic (\> 12 hours) perforation of the intestines~* Secondary peritonitis due to perforated viscus~* Intra-abdominal abscess (including of liver and spleen)~Exclusion Criteria:~* Traumatic bowel perforation requiring surgery within 12 hours~* Perforation of gastroduodenal ulcers requiring surgery within 24 hours~* other intra-abdominal processes in which the primary etiology was unlikely to be infectious.~* Patients lactating or pregnant~* Patients with a history of allergy, hypersensitivity, or any severe reaction to the study antibiotics~* Patients with rapidly progressive or terminal illness;~* Patients with a history or presence of severe hepatic or renal disease (e.g. creatinine clearance \< 0.5 ml/min/1.73 m2);~* Patients with a concomitant infection that would interfere with evaluation of response to the study antibiotics.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- E (Type: EXPERIMENTAL): 3 days regimen with Ertapenem
- AS (Type: ACTIVE_COMPARATOR): 3 days treatment with Ampicillin-Sulbactam

Based on this trial design, predict the completion outcome and termination type (if applicable).